An expensive new drug that could prevent thousands of people from going blind is today approved for use on the NHS after more than two years of deliberations. The National Institute for Health and Clinical Excellence (Nice) says that primary care trusts should foot the bill for Lucentis, which costs £761 for each injection, to prevent people with age-related wet macular degeneration from losing their sight.
Treatment to stop blindness finally approved for NHS - The Guardian 27th August 2008
Wednesday, August 27, 2008
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment